- Dept. of Psychiatry
- In the Headlines
- Medicine Research
- medicine_research mcgill.ca/medicine
- News releases
Study reveals the impact of night work
You cross paths with him at the break of dawn in the corridors of the Metro. He looks bleary-eyed and pallid. This worker’s night shift just ended. His body clocks are out of sync with one another, and, imperceptibly, they’re also out of sync with his environment. In the long run, this night owl could be at greater risk of developing cardiovascular, autoimmune diseases or certain types of cancer.
Newly named Gerald Bronfman Department of Oncology recognizes family’s enduring support
In recognition of the Bronfman family’s enduring support for oncology programs and research at McGill University, the Faculty of Medicine’s Department of Oncology has been named the Gerald Bronfman Department of Oncology, in honour of one of the family’s major benefactors.
Antibiotic resistance represents a major challenge in treating pathogenic bacterial infections.
Now, researchers at McGill University have discovered a possible target for fighting back against resistant bacteria.
Pioneering research at McGill’s Goodman Cancer Research Centre gets boost
The 4th Goodman Cancer Research Gala has raised more than $2.1 million to fund foundational research, more effective diagnostic tools and the development of new treatments and therapies for cancer patients. The Gala was held on Sunday, June 5 in Montreal, bringing together more than 800 guests in support of McGill University’s Rosalind and Morris Goodman Cancer Research Centre.
Neurofeedback using electroencephalograpy boasts thousands of practitioners and appears to both improve normal brain function and alleviate a wide variety of mental disorders – from anxiety to alcoholism. But after examining the scientific literature and consulting experts in Europe and the U.S., McGill University researchers Robert Thibault and Amir Raz conclude that clinical improvements from this increasingly popular alternative therapy are due to placebo effects.
McGill alumnus tagged to boost capacity and discovery in growing field
Dr. Robert Platt, Professor in the departments of Pediatrics and Epidemiology, Biostatistics and Occupational Health at McGill University’s Faculty of Medicine was officially announced as the inaugural Albert Boehringer (1st) Chair in Pharmacoepidemiology during an event held May 26 at McGill.
Op-ed by Howard Bergman, chair of the Department of Family Medicine and Daniel Weinstock, director of the McGill Institute for Health and Social Policy. Montreal Gazette
Op-ed by Christopher Ragan, associate professor of economics. The Globe and Mail
Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing antidepressants for nondepressive indications, including unapproved (off-label) indications that have not been evaluated by regulatory agencies.
Our democratic reform minister doesn’t understand our democracy: Op-ed by Andrew Potter, incoming Director of the McGill Institute for the Study of Canada. National Post
The Right Chemistry: column by Joe Schwarcz, director of McGill University’s Office for Science & Society. Montreal Gazette
“I believe the train is out of control. The damage that this train can eventually do to people who will need to spend huge sums of money at their later stage of life is very, very serious.” Avi Friedman, Professor of Architecture The Globe and Mail
Researchers now have the capability to build virtual reality worlds that can be inhabited by both lab animals (like rats and monkeys) and humans, allowing for a sort of cross-species brain research that’s never really been possible before, as different species are run through virtual environments in video games while scientists study brain activity… In a new study, published in Journal of Neuroscience Methods, a team of neuroscientists—including Martinez-Trujillo, Roberto Gulli and Guillaume Doucet, who are both also affiliated with McGill University—describe a new virtual reality “toolbox”
The Montreal Neurological Institute and Hospital (the Neuro) in Canada to conduct a radical experiment in open science.